https://outline.com/EpGqWm
Dang, ban this.
DeepMind readies first commercial product
81–90 of 134 posts
Re: DeepMind readies first commercial product
#82Earlier quoted context omitted.
you should still complain, this nonsense has to end.
Nonsense? Why do you say that? Is it nonsense that a publication needs to pay its employees? Is it nonsense that non-ad driven revenue allows a publication to focus on quality material versus optimizing for clicks?
You would be right if the article had some unique exclusive information. It doesn't.
Maybe HN should ban paywalled sources.
Re: DeepMind readies first commercial product
#83The cost blowout in healthcare isn't due to diagnosis or care but administrative costs. All these diagnostic AIs won't significantly reduce the cost of healthcare nor improve quality. What we really need is automated administration and billings to really move the needle and that's more human bottlenecked than technology.
Another high cost of healthcare source is the lack of competition on price. You have zero idea how much each procedure costs. Imagine going to a supermarket where there are no price tags, and you must buy the items once you pick them off the shelf. It's madness.
Re: DeepMind readies first commercial product
#84Re: DeepMind readies first commercial product
#85Re: DeepMind readies first commercial product
#86Earlier quoted context omitted.
The cost blowout is a US thing, diagnostic AIs can be used anywhere. And even if the prices weren't affected (which doesn't seem plausible), this can hugely increase the availability and the timeliness of a reliable diagnosis.
Its not a US thing, other countries such as Germany deal with it by making their hospital doctors work insane hours (manditatory 24 hour shifts on weekends from time to time (400-600€ extra for that unless you are in training, then you just have to do it), one assistant doctor for a psych ward over night) and by introducing collective bargaining. So regardless of whether you are a heart surgeon or a dermatologist you…
>It's not a US thing, other countries such as Germany deal with it by making their hospital doctors work insane hours (mandatory 24-hour shifts on weekends from time to time (400-600€ extra for that unless you are in training, then you just have to do it), one assistant doctor for a psych ward overnight)
In fact, it IS "a US thing": • Most major teaching hospitals mandate 24-hour weekend shifts for residents; • One "assistant" aka resident doctor for a psych ward overnight is standard
Retired neurosurgical anesthesiologist here who's been there and done that many, many times....
Re: DeepMind readies first commercial product
#87The cost blowout in healthcare isn't due to diagnosis or care but administrative costs. All these diagnostic AIs won't significantly reduce the cost of healthcare nor improve quality. What we really need is automated administration and billings to really move the needle and that's more human bottlenecked than technology.
Another high cost of healthcare source is the lack of competition on price. You have zero idea how much each procedure costs. Imagine going to a supermarket where there are no price tags, and you must buy the items once you pick them off the shelf. It's madness.
That's funny. I'm not familiar with the US, but are costs not disclosed at all until after they're incurred?
Re: DeepMind readies first commercial product
#88Earlier quoted context omitted.
That has been available since the 1970s. Healthcare is not a very complex compsci issue for 80% of cases. The problem is presentation of symptoms is highly subjective and needs highly complex interpretation that no AI will ever be able to achieve and deal with the liability conundrum
>that no AI will ever be able to achieve The Luddites are back! We'll see how this prediction holds up in 30 years.
That user talked about "liability"
Re: DeepMind readies first commercial product
#89I couldn't read the article, but I wonder if the NHS will get this for free, since we "gave" them all our data in order to train the model.
> A DeepMind spokesperson said that if the research results in a product that passes clinical trials and regulatory approvals, doctors at Moorfields will be able to use the product for free for an initial period of five years.